Follow
Dr. Julio Montaner, OC, OBC, MD, FRCPC, FCCP
Dr. Julio Montaner, OC, OBC, MD, FRCPC, FCCP
Director of the BC-CfE; Director of IDC and Physician Program Director for HIV/AIDS PHC
Verified email at bccfe.ca - Homepage
Title
Cited by
Cited by
Year
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
RK Sterling, E Lissen, N Clumeck, R Sola, MC Correa, J Montaner, ...
Hepatology 43 (6), 1317-1325, 2006
30922006
Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients
FJ Torriani, M Rodriguez-Torres, JK Rockstroh, E Lissen, ...
New England Journal of Medicine 351 (5), 438-450, 2004
16622004
Antiretroviral therapy in adults: updated recommendations of the International AIDS Society–USA Panel
CCJ Carpenter, DA Cooper, MA Fischl, JM Gatell, BG Gazzard, ...
Jama 283 (3), 381-390, 2000
13512000
Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society–USA panel
SM Hammer, JJ Eron, P Reiss, RT Schooley, MA Thompson, S Walmsley, ...
Jama 300 (5), 555-570, 2008
12572008
Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America
JP Lalezari, K Henry, M O'Hearn, JSG Montaner, PJ Piliero, B Trottier, ...
New England Journal of Medicine 348 (22), 2175-2185, 2003
11432003
Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society–USA panel
MA Thompson, JA Aberg, P Cahn, JSG Montaner, G Rizzardini, A Telenti, ...
Jama 304 (3), 321-333, 2010
11132010
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society–USA panel
SM Hammer, MS Saag, M Schechter, JSG Montaner, RT Schooley, ...
Jama 296 (7), 827-843, 2006
11122006
Improved survival among HIV-infected individuals following initiation of antiretroviral therapy
RS Hogg, KV Heath, B Yip, KJP Craib, MV O'shaughnessy, MT Schechter, ...
Jama 279 (6), 450-454, 1998
10481998
A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial
JSG Montaner, P Reiss, D Cooper, S Vella, M Harris, B Conway, ...
Jama 279 (12), 930-937, 1998
9831998
Antiretroviral therapy for HIV infection in 1997: updated recommendations of the International AIDS Society—USA Panel
CCJ Carpenter, MA Fischl, SM Hammer, MS Hirsch, DM Jacobsen, ...
Jama 277 (24), 1962-1969, 1997
9711997
Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy
RS Hogg, B Yip, KJ Chan, E Wood, KJP Craib, MV O'Shaughnessy, ...
Jama 286 (20), 2568-2577, 2001
9632001
Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel
PG Yeni, SM Hammer, CCJ Carpenter, DA Cooper, MA Fischl, JM Gatell, ...
Jama 288 (2), 222-235, 2002
9622002
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study
JSG Montaner, VD Lima, R Barrios, B Yip, E Wood, T Kerr, K Shannon, ...
The Lancet 376 (9740), 532-539, 2010
9112010
Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society–USA Panel
CCJ Carpenter, MA Fischl, SM Hammer, MS Hirsch, DM Jacobsen, ...
Jama 280 (1), 78-86, 1998
8841998
USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
Centers for Disease Control and Prevention
MMWR Morb Mortal Wkly Rep 46 (RR-12), 1-46, 1997
816*1997
Needle exchange is not enough: lessons from the Vancouver injecting drug use study
SA Strathdee, DM Patrick, SL Currie, PGA Cornelisse, ML Rekart, ...
Aids 11 (8), F59-F65, 1997
7871997
Antiretroviral therapy for HIV infection in 1996: recommendations of an international panel
CCJ Carpenter, MA Fischl, SM Hammer, MS Hirsch, DM Jacobsen, ...
Jama 276 (2), 146-154, 1996
7821996
Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel
PG Yeni, SM Hammer, MS Hirsch, MS Saag, M Schechter, CCJ Carpenter, ...
Jama 292 (2), 251-265, 2004
7132004
Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients
HCF Côté, ZL Brumme, KJP Craib, CS Alexander, B Wynhoven, L Ting, ...
New England Journal of Medicine 346 (11), 811-820, 2002
7002002
The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic
JSG Montaner, R Hogg, E Wood, T Kerr, M Tyndall, AR Levy, PR Harrigan
The Lancet 368 (9534), 531-536, 2006
6572006
The system can't perform the operation now. Try again later.
Articles 1–20